| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $8K | -95.3% |
| R&D Expense | $19.0M | +48.8% |
| SG&A Expense | $12.7M | +9.8% |
| Operating Income | -$31.7M | -31.2% |
| Net Income | -$29.9M | -5.6% |
| EPS (Basic) | -$0.95 | +18.1% |
| EPS (Diluted) | -$0.95 | +18.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.6M | -9.1% |
| Short-term Investments | $22.3M | +62.1% |
| Current Assets | $31.5M | +30.3% |
| Total Assets | $34.7M | +24.5% |
| Current Liabilities | $6.9M | +5.3% |
| Total Liabilities | $8.4M | +0.3% |
| Stockholders' Equity | $26.3M | +34.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$21.2M | -4.7% |
| Capital Expenditures | $381K | -62.8% |
| Investing Cash Flow | -$8.1M | +44.8% |
| Financing Cash Flow | $28.5M | -35.2% |
| Free Cash Flow | -$21.6M | -1.5% |